COVID can induce severe inflammatory bone loss: Study

 

 

 

The findings, published in the journal Nature Communications, provides insights into the possible long-term complications of COVID-19

 

SARS-CoV-2 infection can lead to severe bone loss during the acute and postrecovery phases, finds a study.

 

This is caused due to inflammatory activation of bone resorption cells, said researchers from the University of Hong Kong.

 

The findings, published in the journal Nature Communications, provides insights into the possible long-term complications of COVID-19.

 

COVID survivors were so far known to experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body. However, the full spectrum of clinical manifestations, especially the influence of SARS-CoV-2 infection on bone metabolism, has yet to be fully understood.

 

To study the effects of COVID infection on bone metabolism, Syrian hamsters were intranasally challenged with SARS-CoV-2 and then their bone tissues were collected serially after the infection.

 

Using three-dimensional micro-computerised tomography scans, the research team identified that SARS-CoV-2 infection had induced severe bone loss from 20 per cent to 50 per cent progressively, in particular to the trabecular bone, in the long bones and lumbar vertebrae.

 

This effect extended from the acute phase to the chronic phase of infection. The pathological osteopenia – in which the protein and mineral content of bone tissue is reduced was found to be associated with the inflammatory activation of osteoclasts – a kind of cell responsible for bone resorption.

 

The team is the first in the world to report effects of SARS-CoV-2 on bone metabolism using a well-established Syrian hamster model that closely mimics COVID-19 in humans.

 

The findings indicate that the pathological bone loss may be an important but neglected complication, which warrants more extensive investigations during the long-term follow-up of COVID-19 patients.

 

Source :

Express Healthcare

On May 27, 2022

 

 

声明：本站文章版权归原作者及原出处所有。本文章系本站编辑转载，文章内容为原作者个人观点，登载该文章的目的是为了学习交流和研究，并不代表本站赞同其观点和对其真实性负责，本站只提供参考并不构成任何投资及应用建议。

本站是一个学习交流和研究的平台，网站上部分文章为引用或转载，并不用于任何商业目的。我们已经尽可能的对作者和来源进行了告知，但是能力有限或疏忽，造成漏登或其他问题，请及时联系我们，我们将根据著作权人的要求，立即更正或删除有关内容。本站拥有对本声明的最终解释权。